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2• Astronauts frequently report back pain in the early phase of 
space flight as they adapt to microgravity          
• The epidemiology of space adaptation back pain (SABP) has 
not been well established             
Space Adaption Back Pain
3Objectives
• Determine the exact incidence of  SABP 
among astronauts
• Develop a case definition of SABP
• Delineate the nature and pattern of SABP
• Review available treatments and their 
effectiveness in relieving SABP
• Identify any operational impact of SABP
4Methods
Retrospective review of all available mission 
medical records of astronauts in the U.S. space 
program, which included:
• Preflight medical exams
• Flight surgeon logs
• Postflight medical exams
• Postflight medical debriefs
• Standardized back pain questionnaire
• Private Medical Conference (PMC) Tool
5Missions
• Mercury
• Gemini
• Apollo
• Apollo-Soyuz Test Project (ASTP)
• Mir (U.S. Astronauts only)
• Skylab
• International Space Station (ISS) missions        
(Expedition 1 through 15)
• Shuttle missions STS-1 through STS-122                                    
(Except STS-51L Challenger and STS-107 Columbia)
6Study Size
A total of 772 astronaut flights were reviewed
7Case Definition of SABP
• Symptoms are not precipitated by an injury or 
related to prolonged recumbent sitting on the 
launch pad
• Symptoms develop within the first 5 days of 
space flight
• Multiple days of in-flight back pain were 
considered as one case
8Results
Incidence of SABP was 52%
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9Gender Analysis
Comparison of Gender and Space Adaptation Back Pain
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Shuttle Gender Analysis
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SABP Intensity
Mild pain 86%
Moderate pain 11%
Severe pain 3%
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SABP Location
Lumbar 86%
Thoracic 12%
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Onset of SABP
INITIAL DAY SABP  
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Flight Day
In most SABP cases, the initial onset of symptoms was 
within the first 2 days of space flight. Only 12  astronauts 
reported an onset of symptoms after flight day 2 
14
SABP & Flight Days
Flight Days Associated With SABP
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SABP is present in the early phase of spaceflight, with 
a peak prevalence on flight day 2 and none reported 
after flight day 12   
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Temporal Component
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Effectiveness of Treatments 
The most effective treatments were bending the knees to the 
chest (91%), stretching the lumbar spine (90%) and anti-
inflammatory medication (85%) 
Interventions / Results
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Vehicle Analysis
The incidence of SABP varied in relation to the space 
flight vehicle
Space Adaption Back Pain by Vehicle
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History of Pre-flight Back Pain 
                      
Positive History of Preflight Back Pain Anaylsis
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SABP Based on Number of Missions
Percentage of flyers with SABP based on Number of Missions
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Mission
Among astronauts who flew more than one mission; they 
had a higher incidence of SABP on their first mission than 
on subsequent missions
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SABP Characteristics
• Symptoms are usually mild to moderate
• Symptoms are usually localized to the lumbar region
• Symptoms are described as an ache or stiffness
• Symptoms typically occur during the sleep period
• Neurological symptoms (radicular pain, numbness, 
tingling) are absent
• Symptoms tend to improve or resolve with the use of 
bending the knees to the chest, stretching of the 
lumbar spine, or anti-inflammatory medication
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Conclusions
• The incidence of SABP has been determined to be 53% 
among astronauts in the U.S. space program
• Most  cases of SABP are mild, self-limited, or respond to 
available treatments
• There are no currently accepted preventive measures for 
SABP
• It is difficult to predict who will develop SABP
• The precise mechanism and spinal structures responsible 
for SABP are uncertain
• There was no documented evidence of direct operational 
mission impact related to SABP 
• There is potential mission impact related to uncontrolled 
pain, sleep disturbance, or the adverse side effects of anti-
inflammatory medications
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Limitations
• Retrospective study
• Missing data
• Misinterpretation of existing data
• Standardized back pain questionnaire only 
used on Shuttle missions
• Reluctance among astronauts to report        
in-flight back pain
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Recommendations
• Promote the most effective treatments of SABP 
with the least potential for adverse side effects
• Sleep accommodations on all space flight 
vehicles should allow for crewmembers to 
bend their knees to the chest
• The precise mechanism, spinal structures and 
causative factors associated with SABP should 
be further investigated in order to facilitate the 
development of preventive measures, as well 
as additional effective treatments
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